DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine

Detalles Bibliográficos
Autores principales: Anastasopoulou, Eleftheria A, Tzonis, Panagiotis, Fortis, Sotirios P, Mahaira, Louisa, Vaxevanis, Christoforos, Ardavanis, Alexandros, Mittendorf, Elizabeth A, Peoples, George E, Baxevanis, Constantin N, Papamichail, Michael, Perez, Sonia A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652460/
http://dx.doi.org/10.1186/2051-1426-3-S2-P427
Descripción
Sumario:

Ejemplares similares